Transwell migration assays demonstrated that overexpression of RBM47 restrained RCC cells migration ability, while overexpression of HOXB-AS1 could reverse this effect (Fig. 7D and Supplementary Fig. 4A). Here, RBM47 is linked to renal cell carcinoma.